Rajeev Jain
13Patents
6h-index
28Co-inventors
66Inventor score
Filing activity: Sep 4, 1998 → Oct 10, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6316029A | Rapidly disintegrating solid oral dosage form | Emerging Cross-Sectional Technologies | 211 | Expired |
| US6165506A | Solid dose form of nanoparticulate naproxen | Human Necessities | 101 | Expired |
| US8293277B2 | Controlled-release nanoparticulate compositions | Human Necessities | 43 | Expired |
| US7198795B2 | In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions | Human Necessities | 39 | Expired |
| US7276249B2 | Nanoparticulate fibrate formulations | Emerging Cross-Sectional Technologies | 38 | Expired |
| US7320802B2 | Methods of treatment using nanoparticulate fenofibrate compositions | Emerging Cross-Sectional Technologies | 35 | Expired |
| US8309136B2 | In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositions | Human Necessities | 3 | Active |
| US7695739B2 | In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositions | Human Necessities | 3 | Active |
| US7931917B2 | Nanoparticulate fibrate formulations | Emerging Cross-Sectional Technologies | 2 | Active |
| US7998507B2 | Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors | Human Necessities | 2 | Active |
| US7927627B2 | Nanoparticulate fibrate formulations | Emerging Cross-Sectional Technologies | 2 | Active |
| US8236352B2 | Glipizide compositions | Human Necessities | 0 | Active |
| US11564918B2 | Pharmaceutical resinate compositions and methods of making and using thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.